Women’s Health Innovation Social & Showcase @ Stanford
Join us for a casual afternoon bringing together students, builders, and friends interested in women’s health innovation in collaboration with NFX, one of the world's largest early stage VC funds actively investing in women's health.
This gathering will include:
✨ ENGR 307 Final Class Pitches
Student teams from Engineering for Women’s Health will share the ideas they’ve been developing this quarter.
🚀 NFX Women’s Health FAST Competition Introduction
A short introduction to the NFX Women’s Health FAST Competition (150k to 3M SAFE investment), opportunities for students and founders, and insider tips for what VCs look for when investing in the space.
🤝 Community & Networking
An opportunity to meet others working across consumer health, digital health, research, and startups focused on women’s health.
If you’re curious about the future of women’s health innovation, come join the conversation.
Spots are limited — register to receive the location details.
___
About NFX FAST
This Spring, NFX is investing in early-stage Stanford startups (current students, alumni, and faculty) through the FAST competition. Apply for a $150K SAFE (uncapped) or $1-3M SAFE (for 15%) from NFX! All that apply will receive valuable feedback from the NFX team regardless of investment.
Beyond Stanford, our global FAST competition this year is NFX Women's Health 2.0 FAST: a dedicated funding track for founders building category-defining companies in women's health. Apply by April 9th → fast.nfx.com/womens-health-fast-2026
Along with the investment, winners will have access to the entire NFX network and receive exclusive mentorship from the NFX team.
Application Dates: February 16th - April 12th (APPLY NOW!) For more details, visit fast.nfx.com/stanford-fast-2026
About NFX: NFX is the largest pre-seed and seed fund in the world with $450M in its latest fund. Partners have built 11 companies worth >$10 billion. We have invested in 250+ companies including Trulia, Lyft, DoorDash, Poshmark and Patreon, and we've been the first investor in companies like Mammoth Biosciences, Incredible Health, EvenUp, SESO (Stanford), and many others. Recent FAST alumni include Arc (GSB '21), Cambio (GSB '22), Clarative (GSB '23) and Context (Stanford 2024).
On the TechBio side, notable investments include Mammoth Biosciences (Stanford, CRISPR platform co-founded with Nobel Prize winner Jennifer Doudna), Twist Bioscience (~$10B market cap), and C2i Genomics (AI-powered cancer monitoring).